Show/hide main menu

Publications

Recent Publications

Blogosphere:

Global Biopolitics Research Centre (GBRC) blog http://globalbiopoliticsrc.squarespace.com/

ESRC Rising Powers blog http://risingpowersif.blogspot.co.uk/

Citizen Biomedicine https://citizenbiomedicine.wordpress.com/

Featured on Global Medical Discovery December 2014 https://globalmedicaldiscovery.com/?s=salter

Peer Review Journals:

2017

Edison Bicudo (2017)  ‘Big data’ or ‘big knowledge’? Brazilian genomics and the process of academic marketization.   Biosocieties.   

Salter B and Salter C (2017).  Controlling new knowledge: genomic science, governance and the politics of bioinformaticsSocial Studies of Science.  

2016

Salter B, Zhou Y and Datta S (2016): Governing new global health-care markets: the case of stem cell treatments, New Political Economy.  

Bicudo, E. (2016). Genomics Politics through Space and Time: The Case of Bioinformatics in Brazil. Public health genomics, 19(2), 81-92.

Faulkner, A. (2016) Opening the gateways to market and adoption of regenerative medicine? The UK case in context. Regenerative Medicine 11 (3): 321-330.

Salter, B., Zhou, Y., Datta, S. & Salter, C. (2016). Bioinformatics and the politics of innovation in the life sciences: science and the state in the UK, China, and India. Science, Technology and Human Values 1-34. DOI: 10.1177/0162243916631022

Sleeboom-Faulkner, M., Chekar, C.K., Faulkner, A., Heitmeyer, C., Marouda, M., Rosemann, A., Chaisinthop, N., Chang, H.C.J., Ely, A., Kato, M. and Patra, P.K., 2016. Comparing National Home-Keeping and the Regulation of Translational Stem Cell Applications: An International Perspective. Social Science & Medicine.

2015

Salter, Brian, Yinhua Zhou, and Saheli Datta. (2015) "Hegemony in the marketplace of biomedical innovation: Consumer demand and stem cell science." Social Science & Medicine 131: 156-163. http://dx.doi.org/10.1016/j.socscimed.2015.03.015

Hogarth, S. (2015). Neoliberal technocracy: Explaining how and why the US Food and Drug Administration has championed pharmacogenomics. Social Science & Medicine 131: 255-262.

Hogarth, S., 2015. Gene Jockeys: life science and the rise of biotech enterprise. New Genetics and Society, pp.1-2.

Peine, A., Faulkner, A., Jæger, B., & Moors, E. H. (2015). Science, technology and the ‘grand challenge’of ageing—Understanding the socio-material constitution of later life.Technological Forecasting and Social Change.

2014

Salter, Brian, Yinhua Zhou, and Saheli Datta. (2014). "Making Choices: Health Consumers, Regulation and the Global Stem Cell Therapy Market." BioDrugs: 1-4.

Salter, Brian, Yinhua Zhou, and Saheli Datta. (2014).  "Health consumers and stem cell therapy innovation: markets, models and regulation." Regenerative medicine 9 (3): 353-366.

Salter B and Harvey B (2014). Creating problems in the governance of science: bioethics and human/animal chimeras. Science and Public Policy. Published on-line, advanced access, 7 February 2014. doi:10.1093/scipol/sct063

 

Rotolo, D., Hopkins, M., Rafols, I., & Hogarth, S. The Emergence of Molecular Biology in the Diagnosis of Cervical Cancer: A Network Perspective. Science and Technology Indicators (STI) 2014 Leiden, 485.

Peirce, S. C., Faulkner, A., Ulucanlar, S., & Elwyn, G. (2014). Technology identities explain under-and non-adoption of community-based point-of-care tests in the UK NHS. Health Policy and Technology.

Faulkner, A. (2014). Usership of regenerative therapies: Age, ageing and anti-ageing in the global science and technology of knee cartilage repair.Technological Forecasting and Social Change. doi:10.1016/j.techfore.2014.02.020

Book Launched on 5 November 2014.
Edison Bicudo (2014) Pharmaceutical Research, Democracy and Conspiracy. International Clinical Trials in Local Medical Institutions. Ashgate.
Foreword by Professor Brian Salter.

2013

Salter B and Salter C (2013). Bioethical ambition, political opportunity and the European governance of patenting: the case of human embryonic stem cell science. Social Science and Medicine 98: 286-292.

Salter B (2013). Governing innovation paths in regenerative medicine: the European and global struggle for political advantage. In Webster A (ed). The Global dynamics of regenerative Medicine: A social science critique Basingstoke: Palgrave Macmillan.

Faulkner A. (2013) Biomedical techniques and innovation. In WC. Cockerham, R. Dingwall, SR Quah (eds), The Wiley-Blackwell Encyclopedia of Health, Illness, Behavior, and Society, Oxford.

Faulkner, A. (2013) Medical Technology. In Gabe J., Monaghan L. (eds.) Key Concepts in Medical Sociology, 2nd ed. Sage Publications.

Tomlin Z, Faulkner A, Peirce S, Elwyn G. (2013) Technology identity: the role of sociotechnical representations in the adoption of medical devices. Social Science & Medicine.

Sousa, MSA, Franco, MAG, Massud-Filho, J. (2013) The new Declaration of Helsinki and the Use of Placebo in Brazilian Clinical Trials: controversy remains. [From original in Portuguese: A nova Declaração de Helsinque e o Uso de Placebo em Estudos Clínicos no Brasil: a polêmica continua]. Revista de Medicina da Faculdade de Medicina da Universidade de São Paulo [In press].

Sousa, MSA, Gallian, DMC, Maciel, RMB. (2013) Medical Humanities in the UK: a World Trend in Medical Education Today. [From original in Portuguese: Humanidades Médicas no Reino Unido: uma Tendência Mundial em Educação Médica Hoje]. Revista de Medicina da Faculdade de Medicina da Universidade de São Paulo [In press].

Bittar, Y, Sousa, MSA, Gallian, DMC. (2013) The Aesthetic Experience of Literature as Means for Healthcare Humanisation in Brazil: The Laboratory of Humanities from Paulista School of Medicine/Federal University of São Paulo. International Journal of Health, Wellness and Society 3 (1): 25-42. [In press].

Bittar, Y; Sousa, MSA, Gallian, DMC. (2013) The Aesthetic Experience of Literature as Means for Humanisation in Health: The Laboratory of Humanities from EPM/UNIFESP. [From original in Portuguese: A Experiência Estética da Literatura como Meio de Humanização em Saúde: O Laboratório de Humanidades da EPM/UNIFESP]. Revista Interface 17 (44): 171-86. http://dx.doi.org/10.1590/S1414-32832013000100014

PATH project – summary and full report. Tomlin Z, Peirce S, Elwyng G, Faulkner A. (2013) The adoption space of early-emerging technologies: evaluation, innovation, gatekeeping (PATH) (Online)

Hogarth, S., & Sullivan, R. (2013). Genes, genes, genes. The Lancet Oncology,14(3), e88.

Morrison, M., Hogarth, S., & Kewell, B. (2013). Biocapital and Innovation Paths: The Exploitation of Regenerative Medicine. The Global Dynamics of Regenerative Medicine: A Social Science Critique, 58.

2012

Faulkner, A (2012) Commensuration and proliferation: similarity and divergence in law's shaping of medical technology. Law, Innovation and Technology, 4 (2). pp. 165-184.

Faulkner, A (2012) Law's performativities: shaping the emergence of regenerative medicine though European Union legislation. Social Studies of Science, 42 (5). pp. 754-775.

Faulkner, A (2012) Resisting the screening imperative: patienthood, populations and politics in prostate cancer detection technologies for the UK. Sociology Of Health & Illness, 34 (2). pp. 221-233. 

Faulkner, A. (2012). Tissue engineered technologies: regulatory pharmaceuticalization in the European Union. Innovation: The European Journal of Social Science Research, 25(4), 389-408. 10.1080/13511610.2012.723333

Douglas, C. M., van El, C. G., Faulkner, A., & Cornel, M. C. (2012). Governing biological material at the intersection of care and research: the use of dried blood spots for biobanking. Croatian medical journal, 53(4), 390. doi: 10.3325/cmj.2012.53.390

Hogarth, S., Hopkins, M., & Faulkner, A. (2012). Personalized medicine: renewing the social science research agenda. Personalized Medicine, 9(2), 121-126.

Faulkner, A., Lange, B., & Lawless, C. (2012). Introduction: Material Worlds: Intersections of Law, Science, Technology, and Society. Journal of law and society, 39(1), 1-19. DOI: 10.1111/j.1467-6478.2012.00567.x

Faulkner, A. (2012). Steering biomedicine: regulatory dynamics of therapeutic technologies in the European Union and beyond. Innovation: The European Journal of Social Science Research, 25(4), 355-361. full text. DOI:10.1080/13511610.2012.730226

Hogarth, S., Hopkins, M., & Faulkner, A. (2012). Personalized medicine: renewing the social science research agenda. Personalized Medicine, 9(2), 121-126. doi: 10.2217/pme.12.19

Filippakou O, Salter B and Tapper E (2012). Higher Education as a System: The English Experience’ Higher Education Quarterly. 66(1): 106–122 

Harvey A and Salter B (2012). Anticipatory governance: bioethical expertise for human/animal chimeras. Science as Culture. 21(3): 291-313.

Harvey A and Salter B (2012). Governing the moral economy: animal engineering, ethics and the liberal government of science. Social Science and Medicine. 75: 193-199. 

Hogarth, S (2012) Regulatory experiments and transnational networks: the governance of pharmacogenomics in Europe and the United States. Invited contribution for special issue of Innovation: the European Journal of Social Science Research 25(4): 441-460.

Hogarth S, Hopkins M and Rodriguez V. (2012) A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA. Sociology of Health and Illness 34(2): 234-50. (Also available in SHI monograph: Armstrong, N and Eborall, H (eds) The Sociology of Medical Screening: Critical Perspectives, New Directions (Wiley-Blackwell, 2012)).

Hogarth S, Faulkner A and Hopkins, M (2012) Personalized medicine: renewing the social science agenda. Personalized Medicine 9(2): 121-126.

Hopkins M and Hogarth S (2012) Biomarker patents for diagnostics: problem or solution? Nature Biotechnology 30(6): 498-500.

Morrison M, Hogarth S and Kewell B. (2012) Biocapital and innovation paths: the exploitation of regenerative medicine. In  Webster, A. (ed) The Global Dynamics of Regenerative Medicine: a Social Science Critique (Palgrave Macmillan, 2013).

Vàzquez-Salat N, Salter B, Smets G, Houdebine LM (2012). The current state of GMO governance: Are we ready for GM animals? Biotechnology Advances.  

2011

Salter B (2011). Biomedical innovation and the geopolitics of patenting: China and the struggle for future territory. East Asian Science and Technology: An International Journal. 5:1–18.

Salter B and Faulkner A (2011). State strategies of governance in biomedical innovation: aligning conceptual approaches for understanding ‘Rising Powers’ in the global context. Globalisation and Health. 7(3).

Salter B and Waldby C (2011). Biopolitics in China: an introduction. East Asia Science and Technology: An International Journal. 5(3): 287-90. [Special Issue]

Mahalatchimy, A., Rial-Sebbag, E., Tournay, V., & Faulkner, A. (2011). Does the French Bioethics Law create a'moral exception'to the use of human cells for health? A legal and organizational issue. Dilemata, (7), 17-37.

2010

Cooper, M. (2010) Turbulent Worlds: Between Financial and Environmental Crisis. Theory Culture and Society 27(2-3): 2010, 167-190. Special issue on Global Heating.

Filippakou O, Salter B and Tapper T (2010). Compliance, Resistance and Seduction: Reflections on 20 Years of the Funding Council Model of Governance in English Higher Education. Higher Education. 60(5): 543-557.

Frueh, F, Greely, H, Green, R, Hogarth, S and Siegel, S (2011). The future of direct-to-consumer clinical genetic tests. Nature Review Genetics. 12(7): 511-515.

Hogarth, S and Salter, B (2010). Regenerative medicine in Europe: global competition and innovation governance. Regenerative Medicine. 5(6): 971-985

Hogarth, S (2010). Myths, misconceptions and myopia: searching for clarity in the debate about the regulation of consumer genetics. Public Health Genomics. 13(5): 322-326. 

Jones M and Salter B (2010). Proceeding Carefully: assisted human reproduction policy in Canada. Public Understanding of Science. 19 (4): 420-434.

Salter B and Salter C (2010). Governing innovation in the biomedicine knowledge economy: stem cell science in the USA. Science and Public Policy 37(2): 87-100. 

2009

Cooper, M. and Waldby, C. (2009) From Reproductive Work to Regenerative Labour: The Female Body and the Stem Cell Industries. Feminist Theory 11(1).

Faulkner, A (2009) Medical technology into healthcare and society: a sociology of devices, innovation and governance. Health, Technology & Society . Palgrave Macmillan, Basingstoke.

Faulkner A (2009) Regulatory policy as innovation: constructing rules of engagement of a technological zone for tissue engineering in the European Union. Research Policy, 38(4): 637-646.

Fenton L and Salter B (2009). Competition and compromise in negotiating the new governance of medical performance: the clinical governance and revalidation policies in the UK. Health, Economics, Policy and Law. 4: 283-203. 

Gaisser, Hopkins, Liddell, Zika, and Ibarreta (2009). The phantom menace of gene patents. Nature 458: 407-408.

Salter B (2009). China, globalisation and health biotechnology innovation: venture capital and the adaptive state. East Asian Science and Technology: an International Journal. 3(4): 401-420

Salter B (2009). State strategies and the global knowledge economy: the geopolitics of regenerative medicine. Geopolitics. 14: 1-31.

Salter B and Qiu, R. (2009). Bioethical governance and basic stem cell science: China and the global biomedicine economy. Science & Public Policy. 36(1): 47-59.

Saukko, P, Reed, M, Britten, N and Hogarth, S (2009) Negotiating the boundary between medicine and lifestyle: online marketing of nutrigenetic tests. Social Science & Medicine. 70(5): 744-753.

Smith RD, Correa C, Oh C. (2009) Trade, TRIPS, and pharmaceuticals. The Lancet; 373: 684-691.

Webster, A. Douglas, C. Lewis, G. (2009) Making Sense of Medicines: ‘Lay Pharmacology’ and narratives of safety and efficacy. Science as Culture, 18:233-248.

2008

Eriksson, L. and Webster, A. (2008) Standardising the Unknown: practicable pluripotency as doable futures. Science as Culture, 17:57-70.

Faulkner A, Geesink I, Kent, J, Fitz Patrick D (2008) Tissue-engineered technologies: scientific biomedicine, frames of risk and regulatory regime-building in Europe. Science as Culture, 17, 2, 195-222.

Books

Book Launched on 5 November 2014.
Edison Bicudo (2014) Pharmaceutical Research, Democracy and Conspiracy. International Clinical Trials in Local Medical Institutions. Ashgate.
Foreword by Professor Brian Salter.

Stuart Blume (2010) The Artificial Ear: Cochlear Implants and the Culture of Deafness. New Brunswick, NJ, Rutgers University Press.

Faulkner A. (2009) Medical Technology into Healthcare and Society: A sociology of devices, innovation and governance. Basingstoke: Palgrave Macmillan.

Gottweis H, Salter B, Waldby C (2009). The global politics of human embryonic stem cell science: regenerative medicine in transition. Basingstoke: Palgrave.

Smith RD. (2009) Global Health Governance and Global Public Goods. In: Buse K, Hein W, Drager N (eds). Making Sense of Global Health Governance - A policy perspective. Palgrave Macmillan, Basingstoke: chapter 6 (pp122-136).

Webster, A. (2009) Innovative Genetic Technologies, Governance and Social Accountability, in P. Atkinson et al. (eds.) Handbook of Genetics and Society, London: Routledge, pp 486

Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454